Latest News
-
COVID-19 in Africa ‘vastly underestimated’
The number of COVID-19 deaths in Africa could be far greater than those reported, a study published today warns. Read more
-
Challenge testing will trial COVID inoculation
The UK is to run the world’s first challenge testing for COVID-19 vaccine development in a bid to speed up the response to rapidly developing mutations, it has been announced. Read more
-
Neanderthal descendants get COVID protection
Descendants of Neanderthals may enjoy some genetic protection against the COVID-19 virus, according to a new scientific study. Read more
-
Therapy might block multiple sclerosis autoimmune process
A new study has shown how harmful immune cells travel to the brain in people with multiple sclerosis and lead to disease progression. Read more
-
Different growth pattern for IVF children
Children born as a result of fertility treatment may have marginally different growth patterns to others, according to a new study. Read more
-
Promising biomarkers could diagnose mild traumatic brain injury
Specific plasma microRNAs have been found to be diagnostic biomarkers in mild traumatic brain injury, according to researchers in Finland. Read more
-
COVID phase one trials get UK bulk test approach
The UK is to adapt an innovative clinical trial procedure in a bid to fast-track untested new drugs for COVID-19 treatment, it has been announced. Read more
-
Gene variants found to increase Addison’s disease risk
Nine gene variants have been found to increase the risk of developing Addison’s disease, according to the largest genetic study to date on patients with the disorder. Read more
-
Acupressure backed for severe pregnancy sickness
Women with severe pregnancy sickness can be offered acupressure and antiemetics, according to new official guidance. Read more
-
Simple test can identify endometrial cancer
A simple urine or vaginal test carried out at home can accurately detect endometrial cancer – removing the need for painful invasive hospital procedures, a new UK study has found. Read more
